Gulf International Bank (UK)’s AbbVie ABBV Stock Holding History

Gulf International Bank (UK)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.7M	Buy	136,605 +46,969	+52%	+$10.4M	0.66%	21
2025 Q4	$20.5M	Buy	89,636 +112	+0.1%	+$25.5K	0.67%	19
2025 Q3	$20.7M	Sell	89,524 -871	-1%	-$177K	0.68%	22
2025 Q2	$16.8M	Sell	90,395 -11,145	-11%	-$2.07M	0.59%	24
2025 Q1	$21.3M	Sell	101,540 -36,004	-26%	-$7M	0.73%	22
2024 Q4	$24.4M	Sell	137,544 -1,540	-1%	-$283K	0.62%	24
2024 Q3	$27.5M	Sell	139,084 -6,107	-4%	-$1.14M	0.7%	22
2024 Q2	$24.9M	Sell	145,191 -3,912	-3%	-$648K	0.63%	22
2024 Q1	$27.2M	Buy	149,103 +711	+0.5%	+$123K	0.68%	22
2023 Q4	$23M	Sell	148,392 -13,174	-8%	-$1.92M	0.65%	24
2023 Q3	$24.1M	Sell	161,566 -16,521	-9%	-$2.43M	0.68%	22
2023 Q2	$24M	Sell	178,087 -52,424	-23%	-$7.69M	0.6%	26
2023 Q1	$36.7M	Sell	230,511 -64,000	-22%	-$9.78M	0.77%	19
2022 Q4	$47.6M	Buy	294,511 +550	+0.2%	+$84.3K	0.84%	21
2022 Q3	$39.5M	Buy	293,961 +4,500	+2%	+$646K	0.74%	21
2022 Q2	$44.3M	Buy	289,461 +300	+0.1%	+$45.8K	0.79%	20
2022 Q1	$46.9M	Buy	289,161 +130	+0%	+$18.9K	0.7%	21
2021 Q4	$39.1M	Sell	289,031 -60,017	-17%	-$7.09M	0.55%	32
2021 Q3	$37.7M	Sell	349,048 -3,793	-1%	-$433K	0.48%	41
2021 Q2	$39.7M	Sell	352,841 -1,339	-0.4%	-$151K	0.5%	36
2021 Q1	$38.3M	Sell	354,180 -39,907	-10%	-$4.27M	0.53%	37
2020 Q4	$42.2M	Sell	394,087 -27,953	-7%	-$2.69M	0.55%	35
2020 Q3	$37M	Sell	422,040 -4,091	-1%	-$385K	0.52%	39
2020 Q2	$41.8M	Buy	426,131 +71,656	+20%	+$6.31M	0.64%	32
2020 Q1	$27M	Buy	354,475 +3,374	+1%	+$287K	0.51%	44
2019 Q4	$31.1M	Sell	351,101 -1,150	-0.3%	-$95.5K	0.47%	42
2019 Q3	$26.7M	Sell	352,251 -2,051	-0.6%	-$141K	0.44%	50
2019 Q2	$25.8M	Sell	354,302 -1,622	-0.5%	-$127K	0.43%	50
2019 Q1	$28.7M	Sell	355,924 -531	-0.1%	-$43.4K	0.5%	45
2018 Q4	$32.9M	Sell	356,455 -155,939	-30%	-$13.7M	0.65%	29
2018 Q3	$48.5M	Buy	512,394 +21,919	+4%	+$2.08M	0.57%	35
2018 Q2	$45.4M	Sell	490,475 -14,958	-3%	-$1.46M	0.57%	33
2018 Q1	$47.8M	Buy	505,433 +934	+0.2%	+$103K	0.62%	30
2017 Q4	$48.8M	Buy	504,499 +1,900	+0.4%	+$179K	0.62%	30
2017 Q3	$44.7M	Buy	502,599 +3,100	+0.6%	+$236K	0.6%	34
2017 Q2	$36.2M	Sell	499,499 -7,925	-2%	-$533K	0.51%	40
2017 Q1	$33.1M	Buy	507,424 +9,500	+2%	+$597K	0.48%	40
2016 Q4	$31.2M	Buy	497,924 +5,500	+1%	+$336K	0.48%	39
2016 Q3	$31.1M	Buy	492,424 +5,200	+1%	+$337K	0.5%	38
2016 Q2	$30.2M	Sell	487,224 -7,277	-1%	-$443K	0.51%	41
2016 Q1	$28.2M	Hold	494,501	–	–	0.48%	43
2015 Q4	$29.3M	Sell	494,501 -2,740	-0.6%	-$158K	0.51%	39
2015 Q3	$27.1M	Buy	497,241 +450	+0.1%	+$29.3K	0.51%	39
2015 Q2	$33.4M	Buy	496,791 +39,487	+9%	+$2.58M	0.58%	34
2015 Q1	$26.8M	Buy	457,304 +617	+0.1%	+$37.3K	0.48%	46
2014 Q4	$29.9M	Buy	456,687 +9,434	+2%	+$595K	0.53%	38
2014 Q3	$25.8M	Buy	447,253 +2,800	+0.6%	+$155K	0.48%	42
2014 Q2	$25.1M	Hold	444,453	–	–	0.46%	45
2014 Q1	$22.8M	Buy	444,453 +3,756	+0.9%	+$190K	0.45%	47
2013 Q4	$23.3M	Buy	+440,697	New	+$21.7M	0.46%	45

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gulf International Bank (UK)'s ABBV Position: Q1 2026 in Review

Gulf International Bank (UK) increased its AbbVie (ABBV) stake by 52% in Q1 2026, buying an estimated $10.4M and bringing the position to 136,605 shares worth $29.7M. The position accounts for 0.66% of the portfolio, ranked #21.

Gulf International Bank (UK) first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $48.8M in Q4 2017. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Gulf International Bank (UK) held 136,605 shares of AbbVie worth $29.7M as of Q1 2026.
Gulf International Bank (UK) bought 46,969 AbbVie shares in Q1 2026, an estimated $10.4M.
AbbVie made up 0.66% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #21 holding.
Gulf International Bank (UK) first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
Gulf International Bank (UK)'s AbbVie position peaked at $48.8M in Q4 2017.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.